Non-alcoholic fatty liver disease: Definition and subtypes

被引：88
作者：
Han, Seul Ki [1 ,2 ,3 ]
Baik, Soon Koo [1 ,2 ,3 ]
Kim, Moon Young [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea
[2] Yonsei Univ, Regenerat Med Res Ctr, Wonju Coll Med, Wonju, South Korea
[3] Yonsei Univ, Cell Therapy & Tissue Engn Ctr, Wonju Coll Med, Wonju, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2023年 / 29卷
关键词：
Non-alcoholic fatty liver disease; Steatohepatitis; Fibrosis; METABOLICALLY HEALTHY OBESITY; CRYPTOGENIC CIRRHOSIS; RISK-FACTORS; FIBROSIS PROGRESSION; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; HISTOLOGIC FEATURES; STEATOHEPATITIS; ASSOCIATION; PREVALENCE;
D O I：
10.3350/cmh.2022.0424
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of approximately 30%. However, the prevalence of NAFLD has been variously reported depending on the comorbidities. The rising prevalence of obesity in both the adult and pediatric populations is projected to consequently continue increasing NAFLD prevalence. It is a major cause of chronic liver disease worldwide, including cirrhosis and hepatocellular carcinoma (HCC). NAFLD has a variety of clinical phenotypes and heterogeneity due to the complexity of pathogenesis and clinical conditions of its occurrence, resulting in various clinical prognoses. In this article, we briefly described the basic definition of NAFLD and classified the subtypes based on current knowledge in this field.
引用
收藏
页码：S5 / S16
页数：12
相关论文
共 91 条
  • [1] A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
    Abul-Husn, N. S.
    Cheng, X.
    Li, A. H.
    Xin, Y.
    Schurmann, C.
    Stevis, P.
    Liu, Y.
    Kozlitina, J.
    Stender, S.
    Wood, G. C.
    Stepanchick, A. N.
    Still, M. D.
    McCarthy, S.
    O'Dushlaine, C.
    Packer, J. S.
    Balasubramanian, S.
    Gosalia, N.
    Esopi, D.
    Kim, S. Y.
    Mukherjee, S.
    Lopez, A. E.
    Fuller, E. D.
    Penn, J.
    Chu, X.
    Luo, J. Z.
    Mirshahi, U. L.
    Carey, D. J.
    Still, C. D.
    Feldman, M. D.
    Small, A.
    Damrauer, S. M.
    Rader, D. J.
    Zambrowicz, B.
    Olson, W.
    Murphy, A. J.
    Borecki, I. B.
    Shuldiner, A. R.
    Reid, J. G.
    Overton, J. D.
    Yancopoulos, G. D.
    Hobbs, H. H.
    Cohen, J. C.
    Gottesman, O.
    Teslovich, T. M.
    Baras, A.
    Mirshahi, T.
    Gromada, J.
    Dewey, F. E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12) : 1096 - 1106
  • [2] Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
    Angulo, Paul
    Kleiner, David E.
    Dam-Larsen, Sanne
    Adams, Leon A.
    Bjornsson, Einar S.
    Charatcharoenwitthaya, Phunchai
    Mills, Peter R.
    Keach, Jill C.
    Lafferty, Heather D.
    Stahler, Alisha
    Haflidadottir, Svanhildur
    Bendtsen, Flemming
    [J]. GASTROENTEROLOGY, 2015, 149 (02) : 389 - +
  • [3] [Anonymous], 2020, LANCET GASTROENTEROL, V5, P419, DOI [10.1016/S2468-1253(20)30091-1, 10.1053/j.gastro.2019.11.312]
  • [4] Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
    Argo, Curtis K.
    Northup, Patrick G.
    Al-Osaimi, Abdullah M. S.
    Caldwell, Stephen H.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (02) : 371 - 379
  • [5] TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
    Basyte-Bacevice, Viktorija
    Skieceviciene, Jurgita
    Valantiene, Irena
    Sumskiene, Jolanta
    Petrenkiene, Vitalija
    Kondrackiene, Jurate
    Petrauskas, Dalius
    Lammert, Frank
    Kupcinskas, Juozas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
  • [6] The Natural History of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis or Cirrhosis: An International Collaborative Study
    Bhala, Neeraj
    Angulo, Paul
    van der Poorten, David
    Lee, Eric
    Hui, Jason M.
    Saracco, Giorgio
    Adams, Leon A.
    Charatcharoenwitthaya, Phunchai
    Topping, Joanne H.
    Bugianesi, Elisabetta
    Day, Christopher P.
    George, Jacob
    [J]. HEPATOLOGY, 2011, 54 (04) : 1208 - 1216
  • [7] Bondini Silvia, 2007, Clin Liver Dis, V11, P17
  • [8] The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience
    Boulouta, Anna
    Aggeletopoulou, Ioanna
    Kanaloupitis, Stavros
    Tsounis, Efthymios P.
    Issaris, Vasileios
    Papantoniou, Konstantinos
    Apostolos, Anastasios
    Tsaplaris, Paraskevas
    Pastras, Ploutarchos
    Sotiropoulos, Christos
    Tsintoni, Aggeliki
    Diamantopoulou, Georgia
    Thomopoulos, Konstantinos
    Michalaki, Marina
    Triantos, Christos
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (05)
  • [9] Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings
    Brunt, Elizabeth M.
    Kleiner, David E.
    Wilson, Laura A.
    Belt, Patricia
    Neuschwander-Tetri, Brent A.
    [J]. HEPATOLOGY, 2011, 53 (03) : 810 - 820
  • [10] Histopathology of nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Tiniakos, Dina G.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (42) : 5286 - 5296
12345678910